IDEAS home Printed from https://ideas.repec.org/p/iza/izadps/dp14947.html
   My bibliography  Save this paper

Vaccination Policy and Trust

Author

Listed:
  • Jelnov, Artyom

    (Ariel University)

  • Jelnov, Pavel

    (Leibniz University of Hannover and Yezreel Valley College)

Abstract

We study the relationship between trust and vaccination. We show theoretically that vaccination rates are higher in countries with more transparent and accountable governments. The mechanism that generates this result is the lower probability of a transparent and accountable government to promote an unsafe vaccine. Empirical evidence supports this result. We find that countries perceived as less corrupt and more liberal experience higher vaccination rates. Furthermore, they are less likely to adopt a mandatory vaccination policy. One unit of the Corruption Perception Index (scaled from 0 to 10) is associated with a vaccination rate that is higher by one percentage point (pp) but with a likelihood of compulsory vaccination that is lower by 10 pp. In addition, Google Trends data show that public interest in corruption is correlated with interest in vaccination. The insight from our analysis is that corruption affects not only the supply but also the demand for public services.

Suggested Citation

  • Jelnov, Artyom & Jelnov, Pavel, 2021. "Vaccination Policy and Trust," IZA Discussion Papers 14947, Institute of Labor Economics (IZA).
  • Handle: RePEc:iza:izadps:dp14947
    as

    Download full text from publisher

    File URL: https://docs.iza.org/dp14947.pdf
    Download Restriction: no
    ---><---

    Other versions of this item:

    References listed on IDEAS

    as
    1. Lindelow, Magnus & Serneels, Pieter, 2006. "The performance of health workers in Ethiopia: Results from qualitative research," Social Science & Medicine, Elsevier, vol. 62(9), pages 2225-2235, May.
    2. David Croix & Clara Delavallade, 2009. "Growth, public investment and corruption with failing institutions," Economics of Governance, Springer, vol. 10(3), pages 187-219, July.
    3. Jamie M. Sommer, 2020. "Corruption and Health expenditure: A Cross-National Analysis on Infant and Child Mortality," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 32(3), pages 690-717, July.
    4. Mohammad Reza Farzanegan & Hans Philipp Hofmann, 2021. "An Old Plug and a New Virus: Effect of Public Corruption on the Covid-19 Immunization Progress," CESifo Working Paper Series 9307, CESifo.
    5. Goel, Rajeev K. & Nelson, Michael A. & Goel, Viraat Y., 2021. "COVID-19 vaccine rollout—scale and speed carry different implications for corruption," Journal of Policy Modeling, Elsevier, vol. 43(3), pages 503-520.
    6. Charles F. Manski, 2017. "Mandating vaccination with unknown indirect effects," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 19(3), pages 603-619, June.
    7. Lawler, Emily C., 2017. "Effectiveness of vaccination recommendations versus mandates: Evidence from the hepatitis A vaccine," Journal of Health Economics, Elsevier, vol. 52(C), pages 45-62.
    8. Bargain, Olivier & Aminjonov, Ulugbek, 2020. "Trust and compliance to public health policies in times of COVID-19," Journal of Public Economics, Elsevier, vol. 192(C).
    9. R.J. Kolesar & Martine Audibert, 2017. "Postneonatal mortality impacts following grants from the Gavi Vaccine Alliance: an econometric analysis from 2000 to 2014," Post-Print halshs-02006341, HAL.
    10. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
    11. Dietrich, Simone, 2011. "The Politics of Public Health Aid: Why Corrupt Governments Have Incentives to Implement Aid Effectively," World Development, Elsevier, vol. 39(1), pages 55-63, January.
    12. Abrevaya, Jason & Mulligan, Karen, 2011. "Effectiveness of state-level vaccination mandates: Evidence from the varicella vaccine," Journal of Health Economics, Elsevier, vol. 30(5), pages 966-976.
    13. Qiang Li & Lian An & Jing Xu & Mina Baliamoune-Lutz, 2018. "Corruption costs lives: evidence from a cross-country study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(1), pages 153-165, January.
    14. Kim, Daniel & Baum, Christopher F. & Ganz, Michael L. & Subramanian, S.V. & Kawachi, Ichiro, 2011. "The contextual effects of social capital on health: A cross-national instrumental variable analysis," Social Science & Medicine, Elsevier, vol. 73(12), pages 1689-1697.
    15. Martine Audibert & Robert Kolesar, 2017. "Post-neonatal Mortality Impacts Following Grants from the Gavi Vaccine Alliance: An Econometric Analysis from 2000 to 2014," CERDI Working papers halshs-01484982, HAL.
    16. Robert John KOLESAR & Martine AUDIBERT, 2017. "Post-neonatal Mortality Impacts Following Grants from the Gavi Vaccine Alliance: An Econometric Analysis from 2000 to 2014," Working Papers 201707, CERDI.
    17. Martine Audibert & Robert Kolesar, 2017. "Post-neonatal Mortality Impacts Following Grants from the Gavi Vaccine Alliance: An Econometric Analysis from 2000 to 2014," Working Papers halshs-01484982, HAL.
    18. Rajeev K. Goel & Michael A. Nelson, 2021. "Drivers of COVID-19 vaccinations: vaccine delivery and delivery efficiency in the United States," Netnomics, Springer, vol. 22(1), pages 53-69, June.
    19. Rajkumar, Andrew Sunil & Swaroop, Vinaya, 2008. "Public spending and outcomes: Does governance matter?," Journal of Development Economics, Elsevier, vol. 86(1), pages 96-111, April.
    20. Barr, Abigail & Lindelow, Magnus & Serneels, Pieter, 2009. "Corruption in public service delivery: An experimental analysis," Journal of Economic Behavior & Organization, Elsevier, vol. 72(1), pages 225-239, October.
    21. Francis, Peter J., 1997. "Dynamic epidemiology and the market for vaccinations," Journal of Public Economics, Elsevier, vol. 63(3), pages 383-406, February.
    22. Courtney J. Ward, 2014. "Influenza Vaccination Campaigns: Is an Ounce of Prevention Worth a Pound of Cure?," American Economic Journal: Applied Economics, American Economic Association, vol. 6(1), pages 38-72, January.
    23. Brito, Dagobert L. & Sheshinski, Eytan & Intriligator, Michael D., 1991. "Externalities and compulsary vaccinations," Journal of Public Economics, Elsevier, vol. 45(1), pages 69-90, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Bandyopadhyay, Simanti & Kabiraj, Sujana & Majumder, Subrata, 2023. "Subnational governments and COVID management," Economic Modelling, Elsevier, vol. 124(C).
    2. Rughinis, Cosima & Vulpe, Simona Nicoleta & Flaherty, Michael G. & Vasile, Sorina, 2022. "Vaccination, life expectancy, and trust: Patterns of COVID-19 vaccination rates around the world," MPRA Paper 111981, University Library of Munich, Germany.
    3. Galdikiene, Laura & Jaraite, Jurate & Kajackaite, Agne, 2022. "Trust and vaccination intentions: Evidence from Lithuania during the COVID-19 pandemic," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 17(11), pages 1-1.
    4. Blayac, Thierry & Dubois, Dimitri & Duchêne, Sébastien & Nguyen-Van, Phu & Ventelou, Bruno & Willinger, Marc, 2022. "What drives the acceptability of restrictive health policies: An experimental assessment of individual preferences for anti-COVID 19 strategies," Economic Modelling, Elsevier, vol. 116(C).
    5. Chiara F. Del Bo, 2023. "Institutional quality and COVID-19 vaccination: does decentralization matter?," Letters in Spatial and Resource Sciences, Springer, vol. 16(1), pages 1-24, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Neilson, William & Xiao, Yancheng, 2018. "Equilibrium vaccination patterns in incomplete and heterogeneous networks," European Economic Review, Elsevier, vol. 105(C), pages 174-192.
    2. Mohammad Reza Farzanegan & Hans Philipp Hofmann, 2021. "An Old Plug and a New Virus: Effect of Public Corruption on the Covid-19 Immunization Progress," CESifo Working Paper Series 9307, CESifo.
    3. Corey White, 2021. "Measuring Social and Externality Benefits of Influenza Vaccination," Journal of Human Resources, University of Wisconsin Press, vol. 56(3), pages 749-785.
    4. Brilli, Ylenia & Lucifora, Claudio & Russo, Antonio & Tonello, Marco, 2020. "Vaccination take-up and health: Evidence from a flu vaccination program for the elderly," Journal of Economic Behavior & Organization, Elsevier, vol. 179(C), pages 323-341.
    5. Hoffmann, Manuel & Mosquera, Roberto & Chadi, Adrian, 2019. "Vaccines at Work," VfS Annual Conference 2019 (Leipzig): 30 Years after the Fall of the Berlin Wall - Democracy and Market Economy 203661, Verein für Socialpolitik / German Economic Association.
    6. Luca Gori & Cristiana Mammana & Piero Manfredi & Elisabetta Michetti, 2022. "Economic development with deadly communicable diseases and public prevention," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 912-943, October.
    7. Friedman, Willa, 2018. "Corruption and averting AIDS deaths," World Development, Elsevier, vol. 110(C), pages 13-25.
    8. Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
    9. Seth M. Freedman & Daniel W. Sacks & Kosali I. Simon & Coady Wing, 2022. "Direct and indirect effects of vaccines: Evidence from COVID-19," NBER Working Papers 30550, National Bureau of Economic Research, Inc.
    10. Alfano, Vincenzo & Capasso, Salvatore & Ercolano, Salvatore & Goel, Rajeev K., 2022. "Death takes no bribes: Impact of perceived corruption on the effectiveness of non-pharmaceutical interventions at combating COVID-19," Social Science & Medicine, Elsevier, vol. 301(C).
    11. Churchill, Brandyn F., 2021. "How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC's HPV vaccine requirement," Journal of Health Economics, Elsevier, vol. 78(C).
    12. Charles F. Manski, 2021. "Vaccination Planning under Uncertainty, with Application to Covid-19," NBER Working Papers 28446, National Bureau of Economic Research, Inc.
    13. Vu, Trung V., 2020. "Economic complexity and health outcomes: A global perspective," Social Science & Medicine, Elsevier, vol. 265(C).
    14. Jan Hanousek & Evžen Kočenda, 2011. "Public Investment and Fiscal Performance in the New EU Member States," Fiscal Studies, Institute for Fiscal Studies, vol. 32(1), pages 43-71, March.
    15. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
    16. Dzhumashev, Ratbek, 2014. "Corruption and growth: The role of governance, public spending, and economic development," Economic Modelling, Elsevier, vol. 37(C), pages 202-215.
    17. Thomas Wein, 2021. "Ist eine Impfpflicht gegen das Coronavirus nötig? [Is Mandatory Vaccination Against the Coronavirus Necessary?]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, vol. 101(2), pages 114-120, February.
    18. Lawler, Emily C., 2017. "Effectiveness of vaccination recommendations versus mandates: Evidence from the hepatitis A vaccine," Journal of Health Economics, Elsevier, vol. 52(C), pages 45-62.
    19. Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," Working Papers 2020-162, Becker Friedman Institute for Research In Economics.
    20. Mark Gersovitz & Jeffrey S. Hammer, 2004. "The Economical Control of Infectious Diseases," Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.

    More about this item

    Keywords

    corruption; vaccination; COVID-19;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:iza:izadps:dp14947. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Holger Hinte (email available below). General contact details of provider: https://edirc.repec.org/data/izaaade.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.